PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 209 filers reported holding PDL BIOPHARMA INC in Q3 2013. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $140,000 | -39.4% | 47,941 | -41.4% | 0.00% | -50.0% |
| Q1 2020 | $231,000 | -70.1% | 81,762 | -65.7% | 0.01% | -64.7% |
| Q4 2019 | $773,000 | +28.0% | 238,179 | -14.8% | 0.02% | +21.4% |
| Q3 2019 | $604,000 | -37.9% | 279,557 | -9.7% | 0.01% | -36.4% |
| Q2 2019 | $972,000 | -15.6% | 309,526 | 0.0% | 0.02% | -15.4% |
| Q1 2019 | $1,151,000 | +98.8% | 309,526 | +55.1% | 0.03% | +85.7% |
| Q4 2018 | $579,000 | -20.1% | 199,548 | +128.9% | 0.01% | +16.7% |
| Q1 2014 | $725,000 | -37.9% | 87,194 | -37.0% | 0.01% | -40.0% |
| Q4 2013 | $1,168,000 | -57.5% | 138,364 | -59.9% | 0.02% | -60.0% |
| Q3 2013 | $2,751,000 | -21.8% | 345,221 | -24.2% | 0.05% | -24.2% |
| Q2 2013 | $3,517,000 | – | 455,531 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |